click to enlarge picture
click to enlarge picture

INF: Central Service Project: standardized biobanking, human probe and model system evaluation, data-base, bioinformatics

Central issues of the SFB/TR 209 are the quality of materials and models used for the research projects, availability of core data sets to all projects, optimisation of correlative data analyses, and sustainability of the generated results. The majority of projects within the collaborative research centre rely on human probes (70 % of the projects) or innovative mouse models of liver cancer (90 %) and intend to produce moderate to large amounts of hig-throughput data (75 %). The availability of appropriate samples and associated data, sound experimental design, and the consistent generation of high-quality data and metadata are keys for the project success. In addition, cross-project use of bioprobes and data analyses provides one of the main strengths and added value of the consortium. The Central Service Project INF provides three essential and expert-guided functions required for the success of the SFB/TR 209: a) Histotechnology and histopathological evaluation of human tissue probes and mouse model systems used in the different subprojects, biobanking, and harmonisation of cell culture activities, b) data management, database maintenance, and data sustainability, and c) experimental design, data integration/visualization, and bioinformatics support; Project INF will thus provide state-of-the-art infrastructure, work together with researchers from the various projects to plan and conduct the respective experiments, and support them with tailored probes and analyses for and across the projects.
All three project components are based on long standing, successful, and sustainable infrastructures at each location and ask solely for add on funding required to cover the specific activities of the SFB/TR 209. Combination of all three project parts in one INF project provides synergies across the tasks and for complex data analyses.


Penkert J, Ripperger T, Schieck M, Schlegelberger B, Steinemann D, Illig T (2016) On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer. Oncotarget 11759 [epub-ahead].
Bernemann I, Kersting M, Prokein J, Hummel M, Klopp N, Illig T (2016) Centralized biobanks: a basis for medical research. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 59(3):336- 43.
Fuchsberger C, Flannick J, Teslovich TM, Illig T, Boehnke M, Altshuler D, McCarthy MI (2016) The genetic architecture of type 2 diabetes. Nature 4;536(7614):41-7.
Gaulton KJ, Ferreira T, Lee Y… Hamsten A, Illig T, Peters A, Cauchi S, … McCarthy MI, Morris AP (2015) DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet 47(12):1415-25.
Schmitt S, Kynast K, Schirmacher P, Herpel E (2015) Challenges for quality management in implementation, maintenance, and sustainability of research tissue biobanks. Virchows Arch 468(1):93-9.
Herpel E, Koleganova N, Schreiber B, Walter B, Kalle CV, Schirmacher P (2012) Structural requirements of research tissue banks derived from standardized project surveillance. Virchows Arch 461(1):79-86.
Herpel E, Röcken C, Manke H, Schirmacher P, Flechtenmacher C (2010) Quality management and accreditation of research tissue banks: experience of the National Center for Tumor Diseases (NCT) Heidelberg. Virchows Arch 457(6):741-7.
Röst HL, Sachsenberg T, Aiche S, Bielow C, Weisse H, Aicheler F, Andreotti S, Ehrlich HC, Gutenbrunner P, Kenar E, Liang X, Nahnsen S, Nilse L, Pfeuffer J, Rosenberger G, Rurik M, Schmitt U, Veit J, Walzer M, Wojnar D, Wolski WE, Schilling O, Choudhary JS, Malmström L, Aebersold R, Reinert K, Kohlbacher O (2016) OpenMS: a flexible open-source software platform for mass spectrometry data analysis. Nat Methods 13(9):741-8.
Löffler MW, Chandran PA, Laske K, Schroeder C, Bonzheim I, Walzer M, Hilke FJ, Trautwein N, Kowalewski DJ, Schuster H, Günder M, Carcamo Yañez VA, Mohr C, Sturm M, Nguyen HP, Riess O, Bauer P, Nahnsen S, Nadalin S, Zieker D, Glatzle J, Thiel K, Schneiderhan-Marra N, Clasen S, Bösmüller H, Fend F, Kohlbacher O, Gouttefangeas C, Stevanović S, Königsrainer A, Rammensee HG (2016) Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient. J Hepatol 65(4):849-55.
Friedrich A, Kenar E, Kohlbacher O, Nahnsen S (2015) Intuitive Web-based Experimental Design for High-throughput Biomedical Data. Biomed Res Int 5:958302.